{"url_path":"/sec/idya/8-k/2026-06-23/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-23","source_url":"https://www.sec.gov/Archives/edgar/data/1676725/0001193125-26-279427-index.html","accession_number":"0001193125-26-279427","cik":"0001676725","ticker":"IDYA","issuer_name":"IDEAYA Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1676725/0001193125-26-279427-index.html","primary_entity_key":"0001676725","primary_entity_name":"IDEAYA Biosciences, Inc."},"word_count":85,"has_tables":true,"body_markdown":"Item 8.01 Other Events.\n\nEffective June 16, 2026, the Company’s Board of Directors (the “Board”) elected Yujiro S. Hata as Chairman of the Board and Terry Rosen, Ph.D., as the Board’s Lead Independent Director.\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nIDEAYA BIOSCIENCES, INC.\n\nDate: June 23, 2026\n \n\n \nBy:\n \n\n/s/ Yujiro Hata\n\n \n\n \n\n \nYujiro Hata\n\n \n\n \n\n \nPresident and Chief Executive Officer"}